Mortality Rate After Pfizer Vaccine Significantly Higher in European Countries

Strategic Insights -

A recent report from AstraZeneca has raised concerns about the mortality rate associated with the Pfizer coronavirus vaccine in six European countries. According to the 12-page report, titled "Restoring Confidence in COVID-19 Vaccines and Improved Co-operation Between Regulatory, Healthcare Agencies and Pharmaceutical Companies -- A Call for Action," the total number of fatal cases per million administered doses of the vaccine in France, Germany, the UK, Norway, Austria, and Italy is almost three times higher for Pfizer than AstraZeneca. This discrepancy in mortality rates has significant implications for public health and vaccination policies.

Key Takeaways:

  • The mortality rate after the use of the Pfizer coronavirus vaccine in six European countries (France, Germany, the UK, Norway, Austria, and Italy) is significantly higher than after the AstraZeneca vaccine.
  • According to the report, the total number of fatal cases per million administered doses of the vaccine in these countries is almost three times higher for Pfizer than AstraZeneca.
  • France registered 45.3 fatal cases per million doses for Pfizer versus 17.9 for AstraZeneca, while Germany registered 29.9 versus 6.5, and the UK registered 20.7 versus 24.2.
  • The UK prioritizes the use of AstraZeneca for its mass vaccination campaign, and the drug is the main one for several categories of people.
  • Accusations against the Pfizer vaccine impact the credibility of vaccines from other manufacturers and dampen people's willingness to get vaccinated.
  • AstraZeneca noted that the UK drug regulator and scientists have repeatedly stated that the risk of contracting coronavirus greatly outweighs the risk of serious side effects from vaccinations.
  • The company reaffirmed its readiness to cooperate with any scientific bodies in order to ensure vaccination safety based on the principles of full transparency.
  • AstraZeneca is committed to partnering with NITAGs (national immunization technical advisory group) and regulatory bodies to restore confidence in COVID-19 vaccines and vaccination.

Statistics:

  • France: 45.3 fatal cases per million doses for Pfizer versus 17.9 for AstraZeneca.
  • Germany: 29.9 fatal cases per million doses for Pfizer versus 6.5 for AstraZeneca.
  • UK: 20.7 fatal cases per million doses for Pfizer versus 24.2 for AstraZeneca.
  • Norway: 164.3 fatal cases per million doses for Pfizer versus 44.6 for AstraZeneca.
  • Austria: 47.5 fatal cases per million doses for Pfizer versus 7.5 for AstraZeneca.
  • Italy: 10.9 fatal cases per million doses for Pfizer versus 7.3 for AstraZeneca.
  • UK vaccination rate as of May 26: 72.9% of the adult population vaccinated with one dose of the vaccine, 44.8% with both doses.

Sources:

  • AstraZeneca report, "Restoring Confidence in COVID-19 Vaccines and Improved Co-operation Between Regulatory, Healthcare Agencies and Pharmaceutical Companies -- A Call for Action."
  • Sputnik, report from Moscow office of AstraZeneca.
  • Mehr News Agency, provided by SyndiGate Media Inc. (Syndigate.info).